Research firm GoodFirms said on Thursday that the hospitals are adapting various healthcare software to maintain and manage the records to reduce the viral transmission between patients and providers via the exchange of files or prescriptions during the COVID-19 crisis.
In the face of COVID-19, most healthcare departments, pharmacy companies and medical practice institutes have invested in software to keep the information confidential and secure and make it easier to get the data in just one click.
However, various health professionals and healthcare facility providers are facing challenges to pick the right tool. Therefore, GoodFirms.co has evaluated a list of Medical Practice Management, Medical Transcription, Mental Health, Chiropractic, Child Care, Dental Practice, Electronic Medical Records and Hospital Management Software.
The firm is providing Best Medical Practice Management Software, Best Medical Transcription Software, Best Mental Health Software, Best Chiropractic Management Software, Best Child Care Software, Best Dental Practice Software, Best Electronic Medical Records Software as well as Best Hospital Management Software to increase productivity and earn more revenue during the pandemic.
Senhwa Biosciences signs clinical supply agreement with BeOne Medicines
InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy
Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011
D3 Bio completes USD108m Series B financing round
Hemab Therapeutics announces positive Phase 2 multiple ascending dose study results for sutacimig
Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA
Champions Oncology expands bioanalytical services with new technology and leadership
Mirum Pharmaceuticals to acquire Bluejay Therapeutics for HDV treatment
Poolbeg Pharma trial to feature in major CRS research programme
PureTech clears key FDA milestone for Phase 3 development of deupirfenidone
Proteome Sciences wins third US biopharma contract for new clinical assay
Lundbeck reports results from long-term follow-up of epilepsy patients treated with bexicaserin
CARsgen Therapeutics presents CT0596 study data at 2005 ASH Annual Meeting
AsymBio starts commercial production at Shanghai Fengxian Manufacturing Base
Innovent Biologics and Takeda sign global strategic partnership